$175 Million is the total value of HighVista Strategies LLC's 113 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 44.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BCYC | Sell | BICYCLE THERAPEUTICS PLCsponsored ads | $3,181,000 | +25.4% | 136,759 | -9.6% | 1.82% | +18.6% |
| KURA | Sell | KURA ONCOLOGY INC | $2,706,000 | -32.2% | 198,076 | -9.1% | 1.55% | -35.9% |
| FATE | Sell | FATE THERAPEUTICS INC | $2,500,000 | -15.1% | 111,545 | -6.1% | 1.43% | -19.6% |
| DYN | Sell | DYNE THERAPEUTICS INC | $1,301,000 | -21.7% | 102,431 | -57.6% | 0.74% | -25.9% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $885,000 | +23.3% | 8,009 | -16.4% | 0.50% | +16.6% |
| ALNY | Sell | ALNYLAM PHARMACEUTICALS INC | $848,000 | +16.5% | 4,239 | -15.0% | 0.48% | +10.0% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $755,000 | +1.3% | 10,811 | -2.6% | 0.43% | -4.2% |
| MRUS | Sell | MERUS N V | $741,000 | -19.1% | 36,994 | -8.6% | 0.42% | -23.5% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $719,000 | -25.8% | 68,830 | -23.7% | 0.41% | -29.7% |
| CERE | Sell | CEREVEL THERAPEUTICS HLDNG I | $667,000 | -11.3% | 23,611 | -17.0% | 0.38% | -16.1% |
| GHRS | Sell | GH RESEARCH PLCordinary shares | $660,000 | +3.4% | 56,769 | -11.2% | 0.38% | -2.1% |
| ISEE | Sell | IVERIC BIO INC | $611,000 | +9.7% | 34,060 | -41.2% | 0.35% | +3.9% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $600,000 | -26.1% | 12,584 | -40.0% | 0.34% | -30.0% |
| PCVX | Sell | VAXCYTE INC | $501,000 | -17.7% | 20,870 | -25.4% | 0.29% | -22.3% |
| MORF | Sell | MORPHIC HLDG INC | $498,000 | -21.5% | 17,601 | -39.8% | 0.28% | -25.8% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $490,000 | -39.0% | 7,035 | -42.5% | 0.28% | -42.3% |
| RXDX | Sell | PROMETHEUS BIOSCIENCES INC | $462,000 | +52.0% | 7,831 | -27.4% | 0.26% | +43.5% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $368,000 | -21.7% | 12,888 | -32.5% | 0.21% | -26.1% |
| IMGN | Sell | IMMUNOGEN INC | $311,000 | -64.0% | 65,151 | -66.0% | 0.18% | -65.8% |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $283,000 | -21.6% | 17,334 | -30.3% | 0.16% | -25.7% |
| CHTR | Exit | CHARTER COMMUNICATIONS INC Ncl a | $0 | – | -450 | -100.0% | -0.13% | – |
| KSS | Exit | KOHLS CORP | $0 | – | -6,106 | -100.0% | -0.13% | – |
| SCPL | Exit | SCIPLAY CORPORATIONcl a | $0 | – | -15,922 | -100.0% | -0.13% | – |
| IMAB | Exit | I MABsponsored ads | $0 | – | -26,534 | -100.0% | -0.18% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -46,459 | -100.0% | -0.22% | – |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -18,913 | -100.0% | -0.24% | – |
| KROS | Exit | KEROS THERAPEUTICS INC | $0 | – | -16,623 | -100.0% | -0.28% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -12,108 | -100.0% | -0.37% | – |
| NTRA | Exit | NATERA INC | $0 | – | -17,812 | -100.0% | -0.38% | – |
| ARQT | Exit | ARCUTIS BIOTHERAPEUTICS INC | $0 | – | -34,462 | -100.0% | -0.44% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -105,942 | -100.0% | -0.58% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -250,377 | -100.0% | -0.68% | – |
| IDYA | Exit | IDEAYA BIOSCIENCES INC | $0 | – | -130,380 | -100.0% | -1.09% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -74,261 | -100.0% | -1.43% | – |
| TPTX | Exit | TURNING POINT THERAPEUTICS I | $0 | – | -39,384 | -100.0% | -1.79% | – |
| COHR | Exit | COHERENT INC | $0 | – | -13,600 | -100.0% | -2.19% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TRANSDIGM GROUP INC | 29 | Q2 2023 | 2.9% |
| VANGUARD INDEX FDS | 24 | Q4 2019 | 26.4% |
| APPLE INC | 24 | Q4 2019 | 2.0% |
| ISHARES TR | 22 | Q3 2018 | 7.9% |
| MICROSOFT CORP | 21 | Q3 2023 | 2.0% |
| VISA INC | 20 | Q3 2023 | 5.8% |
| INVESCO DB COMMDY INDX TRCK | 20 | Q3 2023 | 16.6% |
| VERIZON COMMUNICATIONS INC | 20 | Q4 2019 | 0.4% |
| ALIBABA GROUP HLDG LTD | 19 | Q3 2023 | 7.7% |
| AMAZON COM INC | 19 | Q3 2023 | 2.9% |
View HighVista Strategies LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STG Group, Inc.Sold out | February 16, 2016 | 0 | 0.0% |
| SAExploration Holdings, Inc. | February 12, 2014 | 25,000 | 0.2% |
| Trio Merger Corp. | February 14, 2013 | 690,000 | 8.8% |
View HighVista Strategies LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View HighVista Strategies LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.